glp-1 obesity drug news today october 2025 The FDA approved Novo Nordisk's once-daily oral Wegovy tablet on December 30, 2025, marking the first oral medication for in the United States and representing a major shift in weight-loss GLP-1 Agonists Weight Loss Drugs
Pay in 4 interest-free payments of $5.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
















:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)







